The Challenges of Urological Research in COVID-19 Era: Lessons Learned for Immediate Response to the Pandemic

Ghoreifi, Alireza; Sobhani, Sina; Moghaddam, Farshad Sheybaee; Djaladat, Hooman

doi:10.1016/j.urology.2022.04.006

Urology

2022

DOI: 10.1016/j.urology.2022.04.006

|View full text |Cite

The Challenges of Urological Research in COVID-19 Era: Lessons Learned for Immediate Response to the Pandemic

Alireza Ghoreifi

Sina Sobhani

Farshad Sheybaee Moghaddam

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2023

Publication Types

Select...

Article2

Relationship

Self Cite1

Independent1

Authors

Journals

Cited by 2 publications

(1 citation statement)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…2 This would limit an optimal selection of a control group. Considering the limitations of research during the COVID pandemic, 3 we tried to minimize the effect of confounders by matching the patients and controls in terms of demographics (ie, sex and age).…”

mentioning

confidence: 99%

Reply by Authors

Ghoreifi

Ladi‐Seyedian

Piatti³

et al. 2023

Journal of Urology

Self Cite

View full text Add to dashboard Cite

mentioning

confidence: 99%

Reply by Authors

Ghoreifi

Ladi‐Seyedian

Piatti³

et al. 2023

Journal of Urology

Self Cite

View full text Add to dashboard Cite

Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions

Lorenc

Rooshenas

Conefrey

et al. 2023

Trials

View full text Add to dashboard Cite

Introduction The COVID-19 pandemic impacted the operationalisation of non-COVID-19 clinical trials globally, particularly site and participant recruitment and trial success/stoppage. Trials which anticipate recruitment challenges may embed methods such as the QuinteT Recruitment Intervention (QRI) to help identify and understand the sources of challenges. Such interventions can help shed light on pandemic-related challenges. This paper reports our experience of the impact of the COVID-19 pandemic on conducting clinical trials with an embedded QRI, highlighting how the QRI aided in identifying challenges and potential solutions, particularly related to the site set-up and participant recruitment. Main body We report on 13 UK clinical trials which included a QRI. Information is from QRI data and researchers’ experience and reflections. In most trials, recruitment was lower than even the lowest anticipated rates. The flexibility of the QRI facilitated rapid data collection to understand and document, and in some instances respond to, operational challenges. Challenges were mostly logistical, pandemic-related and beyond the control of the site or central trial teams. Specifically: disrupted and variable site opening timelines —often due to local research and development (R&D) delays— shortages of staff to recruit patients; fewer eligible patients or limited access to patients; and intervention-related factors. Almost all trials were affected by pandemic-related staffing issues including redeployment, prioritisation of COVID-19 care and research, and COVID-19-related staff illness and absence. Trials of elective procedures were particularly impacted by the pandemic, which caused changes to care/recruitment pathways, deprioritisation of services, reduced clinical and surgical capacity and longer waiting lists. Attempted solutions included extra engagement with staff and R&D departments, trial protocol changes (primarily moving online) and seeking additional resourcing. Conclusion We have highlighted wide-ranging, extensive and consistent pandemic-related challenges faced by UK clinical trials, which the QRI helped to identify and, in some cases, address. Many challenges were insurmountable at individual trials or trials unit level. This overview highlights the need to streamline trial regulatory processes, address staffing crises, improve recognition of NHS research staff and for clearer, more nuanced central guidance on the prioritisation of studies and how to deal with the backlog. Pre-emptively embedding qualitative work and stakeholder consultation into trials with anticipated difficulties, moving some processes online, and flexible trial protocols may improve the resilience of trials in the current challenging context.

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

The Challenges of Urological Research in COVID-19 Era: Lessons Learned for Immediate Response to the Pandemic

Cited by 2 publications

References 19 publications

Reply by Authors

Reply by Authors

Non-COVID-19 UK clinical trials and the COVID-19 pandemic: impact, challenges and possible solutions

Contact Info

Product

Resources

About